News archives

Nomura International makes a significant investment In Phytopharm

12 December 1997

Following notification yesterday from Ethical Holdings plc and Nomura International plc, Phytopharm announces that Nomura International plc has acquired a 17.1 per cent shareholding in the company from Ethical Holdings. This represents the disposal of the balance of Ethical’s shareholding in Phytopharm. Ethical was a 28.5 per cent shareholder in the company immediately following Phytopharm’s flotation in April 1996.

Preliminary results for the year ended 31 August 1997 regulatory filing completed in the US

5 December 1997

For the 1997 Preliminary Results

Phytopharm appoints Financial Adviser

29 July 1997

The Board of Phytopharm plc announces that it has appointed N M Rothschild & Sons Limited as the company’s financial advisers.

Phytopharm to develop natural Anti-obesity treatment

23 June 1997

A naturally occurring appetite suppressant is to be developed into a prescription medicine by Phytopharm plc in collaboration with the prestigious South African statutory scientific research council, the CSIR. Animal studies have shown the plant extract to be highly effective when compared with currently available treatments.

Phytopharm announces appointment of new Chairman

1 May 1997

The Board of Directors of Phytopharm plc today announced that Gordon Stevens has been appointed non-executive Chairman with effect from 3 May 1997. From 1976 until 1988, Mr Stevens was a director of Unilever plc and Unilever NV and, in 1996, he retired from his positions as Chairman of Scholl plc and WPP Group plc.

Preliminary results for the year ended 31 August 1996

28 October 1996

For the 1996 Preliminary Results